Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML

Here we evaluated whether sequential high-dose chemotherapy (sHD) increased the early complete remission (CR) rate in acute myelogenous leukemia (AML) compared with standard-intensity idarubicin-cytarabine-etoposide (ICE) chemotherapy. This study enrolled 574 patients (age, 16-73 years; median, 52 y...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood Adv
Main Authors: Bassan, Renato, Intermesoli, Tamara, Masciulli, Arianna, Pavoni, Chiara, Boschini, Cristina, Gianfaldoni, Giacomo, Marmont, Filippo, Cavattoni, Irene, Mattei, Daniele, Terruzzi, Elisabetta, De Paoli, Lorella, Cattaneo, Chiara, Borlenghi, Erika, Ciceri, Fabio, Bernardi, Massimo, Scattolin, Anna M., Todisco, Elisabetta, Campiotti, Leonardo, Corradini, Paolo, Cortelezzi, Agostino, Ferrero, Dario, Zanghì, Pamela, Oldani, Elena, Spinelli, Orietta, Audisio, Ernesta, Cortelazzo, Sergio, Bosi, Alberto, Falini, Brunangelo, Pogliani, Enrico M., Rambaldi, Alessandro
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2019
Teme:
Clinical Trials and Observations
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6457212/
https://ncbi.nlm.nih.gov/pubmed/30948365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018026625
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki